Showing results (61-70 of 307) with videos related to
Sort By:
Pageof 31
European Journal of Cancer & Clinical Oncology|November 1, 1987
Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning systemC L Arteaga, D L Kisner, A Goodman, et al.Anticancer Research|July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)S I Kim, D C Chen, F M MuggiaInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1984
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologiesF M Muggia, R H Blum, J D ForemanInvestigational New Drugs|January 1, 1985
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot studyR H Earhart, F M Muggia, F M GolombInvestigational New Drugs|January 1, 1984
Activity of Carbetimer in a human tumor cloning systemD L Kisner, P Mehta, G E Paget, et al.Medical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.Biochemical Pharmacology|May 1, 1987
Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitroS Wadler, M D Green, R Basch, et al.Cancer Investigation|January 1, 1989
Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndromeA Chachoua, M D Green, F Valentine, et al.Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.Pageof 31